WINT logo

Windtree Therapeutics (WINT) Company Overview

Profile

Full Name:

Windtree Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

August 7, 1995

Indexes:

Not included

Description:

Windtree Therapeutics (WINT) is a biotechnology company focused on developing treatments for serious lung diseases. They work on innovative therapies to improve breathing and overall lung health, aiming to help patients with conditions like respiratory distress and pulmonary diseases.

Events Calendar

Earnings

Next earnings date:

Apr 17, 2025

Recent quarterly earnings:

Nov 27, 2024

Recent annual earnings:

Apr 17, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 21, 2025

Analyst ratings

Recent major analysts updates

Dec 4, 24 HC Wainwright & Co.
Neutral
Jan 3, 24 HC Wainwright & Co.
Neutral
Jun 4, 21 Oppenheimer
Outperform
Nov 25, 20 Ladenburg Thalmann
Buy
Nov 25, 20 H.C. Wainwright
Buy
Jun 26, 20 Ladenburg Thalmann
Buy
Apr 22, 16 H.C. Wainwright
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Windtree Therapeutics?
  • Does Windtree Therapeutics pay dividends?
  • What sector is Windtree Therapeutics in?
  • What industry is Windtree Therapeutics in?
  • What country is Windtree Therapeutics based in?
  • When did Windtree Therapeutics go public?
  • Is Windtree Therapeutics in the S&P 500?
  • Is Windtree Therapeutics in the NASDAQ 100?
  • Is Windtree Therapeutics in the Dow Jones?
  • When was Windtree Therapeutics's last earnings report?
  • When does Windtree Therapeutics report earnings?
  • Should I buy Windtree Therapeutics stock now?

What is the ticker symbol for Windtree Therapeutics?

The ticker symbol for Windtree Therapeutics is NASDAQ:WINT

Does Windtree Therapeutics pay dividends?

No, Windtree Therapeutics does not pay dividends

What sector is Windtree Therapeutics in?

Windtree Therapeutics is in the Healthcare sector

What industry is Windtree Therapeutics in?

Windtree Therapeutics is in the Biotechnology industry

What country is Windtree Therapeutics based in?

Windtree Therapeutics is headquartered in United States

When did Windtree Therapeutics go public?

Windtree Therapeutics's initial public offering (IPO) was on August 7, 1995

Is Windtree Therapeutics in the S&P 500?

No, Windtree Therapeutics is not included in the S&P 500 index

Is Windtree Therapeutics in the NASDAQ 100?

No, Windtree Therapeutics is not included in the NASDAQ 100 index

Is Windtree Therapeutics in the Dow Jones?

No, Windtree Therapeutics is not included in the Dow Jones index

When was Windtree Therapeutics's last earnings report?

Windtree Therapeutics's most recent earnings report was on Nov 27, 2024

When does Windtree Therapeutics report earnings?

The next expected earnings date for Windtree Therapeutics is Apr 17, 2025

Should I buy Windtree Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions